CBNLCF
BMY icon

Cognios Beta Neutral Large Cap Fund’s Bristol-Myers Squibb BMY Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,010
Closed -$274K – 100
2023
Q1 		$274K Sell
4,010
-233
-5% -$16.4K 0.26% 103
2022
Q4 		$305K Buy
+4,243
New +$320K 0.29% 103

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cognios Beta Neutral Large Cap Fund's BMY Position: Q2 2023 in Review

Cognios Beta Neutral Large Cap Fund sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 4,010 shares — an estimated $274K sold.

Cognios Beta Neutral Large Cap Fund first reported a position in BMY in Q4 2022 and held it in 2 quarters. The position peaked at $305K in Q4 2022. 2,480 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Cognios Beta Neutral Large Cap Fund reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Cognios Beta Neutral Large Cap Fund sold 4,010 Bristol-Myers Squibb shares in Q2 2023, an estimated $274K.
  • Cognios Beta Neutral Large Cap Fund first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 2 quarters.
  • Cognios Beta Neutral Large Cap Fund's Bristol-Myers Squibb position peaked at $305K in Q4 2022.
  • 2,480 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q2 2023, filed 3 Aug 2023.